News Releases

Updates every hour. Last Updated: 28-Jun-2026 12:16 ET (28-Jun-2026 16:16 GMT/UTC)

25-Jun-2026

UT Health San Antonio researcher receives $400,000 Komen grant to study therapeutic yoga for breast cancer survivors

The University of Texas at San Antonio Health Science Center
Grant and Award Announcement

UT Health San Antonio cancer researcher Amelie G. Ramirez, DrPH, aims to enhance recovery for breast cancer survivors through the study of therapeutic yoga with a two-year, $400,000 grant from Susan G. Komen.

25-Jun-2026

 

Scientists measure hidden quantum forces that could power a new generation of pharmaceutical drugs

Texas A&M University
Peer-Reviewed Publication

Researchers invent a laser technique that reveals the hidden forces shaping proteins, advancing a future of precision medicine engineered with quantum precision.

Journal

Science Advances

Funder

Air Force Office of Scientific Research, Army Research Laboratory

25-Jun-2026

A molecular seesaw drives healthy skin development, Stanford Medicine researchers find

Stanford Medicine
Peer-Reviewed Publication

Two opposing biological pathways balance stem cell maintenance with skin development; topical drug treatments targeting them may treat skin cancers and disorders.

Journal

Science

25-Jun-2026

 

U of A researchers' new approach boosts immune response against lung cancer

University of Arizona
Peer-Reviewed Publication

A chemotherapy drug and a gene-silencing molecule exploit an “eat me” signal on dying cancer cells to stop tumor growth.

Journal

Nature Communications

Funder

National Institutes of General Medical Sciences (NIGMS) and the National Cancer Institute

25-Jun-2026

AI framework aids target discovery for CAR T cell therapy

University of Pennsylvania School of Medicine
Peer-Reviewed Publication

Leading CAR T cell therapy researchers from Penn Medicine have developed a human-in-the-loop artificial intelligence (AI) framework that firmly centers scientists’ expertise to find viable target antigens for CAR T cell therapy.

Journal

Cell

25-Jun-2026

UCLA researchers awarded $1.7 million Department of Defense grant to advance next-generation CAR T-cell therapies for prostate cancer

University of California - Los Angeles Health Sciences
Grant and Award Announcement

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center have received a $1.7 million grant from the U.S. Department of Defense’s Congressionally Directed Medical Research Programs (CDMRP) to develop new strategies to improve CAR T-cell therapies for metastatic castration-resistant prostate cancer, an advanced form of the disease with limited treatment options.

25-Jun-2026

 

Microscale hydrogel fibers could enable imaging inside tiny tissue structures

Optica
Peer-Reviewed Publication

Researchers combined adaptive optics and parallel optical coherence tomography to capture high-speed, 3D views of individual cells in the living retina. This non-invasive advance could drastically improve the early  detection and monitoring of chorioretinal diseases. 

25-Jun-2026

Mayo Clinic researchers uncover critical link in the immune response to cancer

Mayo Clinic
Peer-Reviewed Publication

Researchers at Mayo Clinic have uncovered a previously hidden step in how the immune system prepares to fight cancer, a discovery that could help scientists develop more effective and longer-lasting cancer immunotherapies.

Journal

Nature Communications

25-Jun-2026

 

Metabolic reprogramming and epigenetic regulation: The dual role of lactate and lactylation in pancreatic ductal adenocarcinoma progression and therapeutics

FAR Publishing Limited
Peer-Reviewed Publication

Recent findings published in Current Molecular Pharmacology reveal that lactate, once dismissed as a metabolic waste product, drives pancreatic cancer progression through dual roles as a fuel and signaling molecule. The study highlights lactylation—a novel protein modification—as a key epigenetic regulator in tumor growth, immune suppression, and therapy resistance.

Journal

Current Molecular Pharmacology

25-Jun-2026

 

PVT1&EIF4A1 promote metastasis through regulating Notch-1 signaling pathway via STC-1 in gastric cancer

FAR Publishing Limited
Peer-Reviewed Publication

A new study in Current Molecular Pharmacology reveals that the lncRNA PVT1 binds to the translation factor EIF4A1 and drives gastric cancer progression by upregulating STC1. STC1 then activates Notch1 signalling and epithelial–mesenchymal transition, promoting metastasis. The findings identify STC1 as a potential therapeutic target and diagnostic marker for aggressive gastric cancer.

Journal

Current Molecular Pharmacology